close
close

TELA Bio reports second quarter 2024 financial results and reiterates full year 2024 revenue guidance

TELA Bio reports second quarter 2024 financial results and reiterates full year 2024 revenue guidance

MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on delivering innovative solutions for soft tissue reconstruction, today reported financial results for the second quarter ended June 30, 2024.

Recent highlights